The Covid-19 pandemic has clearly demonstrated a need to transform both the organization and delivery of health care on a global level. Of course, it also revealed the ingenuity and resilience of health care workers and business leaders, who met 2020’s global health care challenges head-on with new, sustainable solutions.
From improving organization efficiency and fast-tracking new digital treatment avenues to increasing accessibility to care worldwide, there are countless initiatives that need to be addressed if we are to build solid foundation for the future. Of course, to accomplish such sweeping changes on a global scale will require collaboration and the free exchange of ideas.
World of Health Care allows foreign decision-makers in healthcare to visit and share knowledge with Dutch health stakeholders and other countries present. WoHC Delegates participate in the Health~Holland Visitors Programme, a 3-day virtual program for decision-makers in international, national, regional, and local healthcare. This program aims to broaden the knowledge of our worldwide renowned Dutch Health system and related smart solutions which increase the quality, affordability, and accessibility of healthcare.
To get a sense of last year’s high-level delegates, please visit: high-level delegates 2020
Last year, 100+ high-level representatives from the private sector, NGO’s, knowledge institutes and different tiers of government from 25 countries joined the WoHC virtual sessions and networking. Boasting 500 international participants from 30+ countries, the 2021 World of Health Care is sure to be a truly inspirational event. Each day will provide ample opportunities for networking and collaboration. Also, both Dutch and international stakeholders will be able to join plenary sessions and actively search for partners via our B2B matchmaking platform.
KLSC will be represented by Chief Business Development Officer, Dr. Mussaad M. Al-Razouki.
-Ends-
About KLSC:
Kuwait Life Sciences (KLSC) was established in 2010, with a paid-up capital of 18 million Kuwait Dinars (KD) which is equivalent to approximately $60 million US Dollars. KLSC is fully owned by National Technology Enterprises Company. National Technology Enterprises Company (NTEC) was incorporated in November of 2002, by the Kuwait Council of Ministers as a fully owned company by the Kuwait Investment Authority (KIA), the sovereign wealth fund of the State of Kuwait. Capitalized at 100 million Kuwait Dinars (KD) which is equivalent to approximately $350 million US Dollars, NTEC aims to play a vital role in servicing major stakeholders in Kuwait and the Middle East region with their technology requirements.
KLSC focuses on healthcare innovative concepts and demanded services that have a clear and unmet need in the Middle East and North Africa (MENA) region. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the pioneer venture capitalist and private equity companies in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems within the region. KLSC supports both public and private sector stakeholders to access emerging technologies, establish unique projects and adopt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, life sciences training, medical technology, and pharmaceutical distribution.
For Further Press Enquiries:
Email KLSC at: info@klsc.com.kw
Our mailing address is:
KIPCO Tower, 27th floor, Block 9
Al Shohadaa Street, Sharq
P.O.Box 25363, Safat 13114 Kuwait
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
